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HIV-Associated Neurocognitive Disorders (HANDs) are becoming one of the 
largest problems in patients infected with HIV-1. The ability of infected cells such as 
monocytes and microglial cells to act as viral reservoirs causes extreme inflammation in 
the CNS and has led to several different types of neurocognitive problems. Specifically 
these HIV-1 infected monocytes are able to secrete inflammatory factors such as the 
regulatory protein Tat which acts as a chemoattractant for monocytes while also promoting 
the adhesion of leukocytes to the extracellular matrix (ECM).  
We have shown that one of the major features of the Tat protein is that it promotes 
cytoskeletal rearrangement resulting in increased adhesion. Specifically integrin and actin 
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visualization was performed using confocal immunofluorescence while cytoskeletal 
morphology was shown with light and SEM. This microscopy work showed the Tat 
protein resulted in altered β1-integrin expression and distribution as well as changes in 
polymerized actin. These cytoskeletal changes resulted in increased adhesion to the ECM. 
Similarly we have also shown that these cytoskeletal changes of β1-integrin distribution 
and polymerized actin can be modulated through select cannabinoids THC and CP55940 
that bind through the CB2 receptor which inhibits this adhesion as well as the 
morphological changes. The modulation of this reorganization is characteristic of a signal 
transduction pathway where a novel convergent point between extracellular Tat and the 
select cannabinoids THC and CP55940 exists. The aim of this project was to show the 
cytoskeletal reorganization using different microscopy techniques including light and 
scanning electron microscopy. This was followed by identifying and characterizing the 
convergent point along the signal transduction pathway linked to these changes. Different 
techniques were utilized in order to identify the putative convergent point in the signal 
transduction cascade including antibody arrays, RT-PCR, and western immunoblotting.  
The cytoskeletal rearrangements of β1-integrin and actin polymerization were 
shown successfully via light and scanning electron microscopy in the context of treatment 
with Tat in the presence and absence of select cannabinoids THC and CP55940. Several 
different pathways were identified as possibly linked to cannabinoid-mediated inhibition of 
signal transductional activation consequent of attachment to extracellular matrix proteins. 
However, the exact molecules implicated in specific signal transductional pathways as 
targets of cannabinoid-mediated action remain to be defined.  
  10 
 
 
 
 
Introduction 
 
 
Due to the application of highly active antiretroviral therapy (HAART), the 
survival rate of patients diagnosed with HIV infection has increased. However, although 
the viral load in these patients has decreased, there is one problem that remains-- the 
development HIV-Associated Neurocognitive Disorders (HAND) (Strazza et al., 2011).  
Cognitive impairment occurs in a substantial number (15-50%) of HIV-infected patients 
(Goodkin et al., 1995). There are three classifications of HAND, HIV-associated dementia 
(HAD), minor cognitive motor disorder, and asymptomatic neurocognitive impairment. Of 
those infected with HIV-1, approximately 15% develop HAD and 30 to 60% develop less 
severe forms of HAND (Gendelman et al., 2005; McArthur, 2004). Due to the longevity of 
patient life through HAART the prevalence of milder HAND has increased (Ances et al., 
2008). While the pathological mechanisms underlying HAND are unknown, studies 
suggest that HIV-specified proteins, as well as advanced age and co-morbid 
neurodegenerative disease, act together resulting in the clinical presentation of this disorder 
(Ghafouri et al., 2006). It is thought that HIV-1 enters the CNS through transmigration of 
virally-infected leukocytes early in the infection. These infected macrophages secrete 
chemokines, cytokines, and toxic viral proteins such as trans-activating protein (Tat) and 
gp120 which compromise the integrity of the blood brain barrier (BBB). Through 
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disruption of the blood brain barrier toxic viral proteins gain access to the CNS through 
different modes. Clinical manifestations associated with HAND include, impaired mental 
concentration, slowness of hand movements, and difficulty walking. The immunological 
pathologies include widespread reactive astrocytosis, myelin pallor, as well as infiltration 
of blood-derived macrophages, resident microglia, and multinucleated giant cells. (Lipton 
et al., 1995).  
One issue with retroviral therapy is that, in spite of HAART treatment, certain 
proteins may be secreted by the virus-infected cells that can still act on neighboring cells. 
HIV-infected macrophages have been shown to secrete chemokines, cytokines, and viral 
products that include the HIV-1 Trans-activator of Transcription (Tat) protein (Ensoli et 
al., 1993). The Tat protein can interact with neighboring cells in two ways, extracellular 
Tat may be taken up by cells and enter the nucleus and alter gene regulation or it can 
interact with cell receptors on the surface (Albini et al., 1996). The extracellular Tat 
protein can cause an inflammatory response in the CNS through increased production of 
proinflammatory cytokines, chemokines, and adhesion molecules (Conant et al., 1998; 
Dallasta et al., 1999). The Tat protein has been detected in the serum, blood and cerebral 
spinal fluid (CSF) of HIV-1 infected individuals (Nath et al., 1998a). The Tat protein has 
been detected at a concentration of 16 ng/mL in the CSF, 0.1-1nM in the blood and at 
concentrations of 1-3 ng/mL in serum (Westendorp et al., 1995; Nath et al., 1998a). There 
are several neurotoxic actions of extracellular Tat that include, but are not limited to, 
depolarization of neurons, increased levels of intracellular calcium, increased 
production/release of pro-inflammatory cytokines, increased macrophage infiltration, 
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activation of excitatory amino acid receptors, and increased apoptosis (Nath et al., 1998b; 
New et al., 1997; Chang et al., 1997).  
Most regimens of retroviral therapy (RT) utilize nucleoside analog reverse 
transcriptase inhibitors (NRTIs), that consist of two NRTIs as well as a protease inhibitor 
(PI) (Dybul et al., 2002). However, Tat is not responsive to the action of protease and 
deoxynucleoside inhibitors. Because the Tat protein is not responsive to HAART, it can 
cause inflammation in the brain. Therefore, by treating the inflammatory process caused by 
extracellular Tat, a much more complete regimen for HIV could be used to treat HAND.  
The gene for Tat is comprised of two exons, one in the central region of the 
proviral genome making up the most conserved portion of the protein (amino acids 1-72), 
and the other overlaping the envelope gene. The spliced tat mRNA is translated into an 86-
101 amino acid protein that transactivates proviral transcription through interaction with 
the RNA hairpin as well as conditioning the functioning of the LTR-driven transcription 
complex (Marzio et al., 1998). The Tat protein has distinct domains, an N-terminal domain 
(amino acids 1-20), a cysteine rich  (amino acids 21-40), a core domain (amino acids 41-
48), a basic domain (amino acids 49-72), and a C-terminal domain (amino acids 73-101) 
(Fig. 1). The C-terminal domain also contains an Arginine-Glycine-Aspartic Acid (RGD) 
motif which is typical of extracellular matrix proteins (Jones et al., 1994). This RGD 
domain is known as the key site for integrin receptor adhesion (Brake et al., 1990). 
There are several functions elicited by the Tat protein, one of which is the induction 
of chemokine and cytokine production. Extracellular Tat then will activate neighboring 
cells triggering more chemokine and cytokine production (D'Aversa et al., 2004); (Eugenin 
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et al., 2005). One of the major features of the Tat protein is molecular mimicry to 
components that bind extracellular matrix proteins. The protein has this ability due to two 
functional regions, the basic domain which binds basic fibroblast growth factor (bFGF) 
from heparin sulfate proteoglycans (Barillari et al., 1999a; Barillari et al., 1999b; Chang et 
al., 1997) and the RGD region which binds the α5β1 and αVβ3 integrins (Barillari et al., 
1993). Extracellular Tat protein alters adhesion through the use of three different receptors: 
integrins, VEGF receptors, and chemokine receptors. The protein does this by binding to 
receptors and inducing inflammatory genes as well as activating the universal 
transcriptional factor nuclear factor- kB (NF-kB) (Conant et al., 1998). Activated NF-kB 
then activates transcription of genes involved in cytokine and chemokine production as 
well as that of adhesion molecules (Barnes, 1997). 
The Tat protein also has been shown to have effects on primary human brain 
microvascular endothelial cells (HBMECs) that result in HIV-associated dementia (HAD). 
Tat alters, the permeability of the blood brain barrier (BBB), through the interaction with 
HBMECs, resulting in infiltration of infected and uninfected monocytes into the CNS 
(Avraham et al., 2004). Upon treatment of monocytes with Tat protein an upregulation in 
β1-integrins, extracellular matrix proteins used for attachment and signal transduction, was 
shown in a monocyte-derived cell line (Lafrenie et al., 1996). This upregulation was 
associated with enhanced monocyte adhesion to cytokine activated endothelial layers 
(Cavender et al., 1991). In fact, it has been shown that HIV Tat-treated monocytes 
synthesize three times more β1-integrins than untreated cells (Lafrenie et al., 1996). Once 
these primary monocytes are bound, it has been shown that Tat1-72 can stimulate monocyte 
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entry into the brain (Pu et al., 2003). These infected monocytes, which are acting as 
reservoirs for viral replication, cross the BBB and enter the CNS resulting in inflammation 
of brain tissue that could lead to HAD. The Tat protein has been shown to disrupt the 
blood-brain barrier in vitro and in vivo, resulting in infiltration of monocytes into the CNS 
through the disruption of tight junctions leading to HIV entry into the brain. This 
disruption of the blood-brain barrier appears to result in infiltration of monocytes, which 
can act as viral reservoirs as well as cause inflammation due to an accumulation of 
perivascular macrophages. (Toborek et al., 2003; Andras et al., 2003; Cooper et al., 2012).  
The extracellular matrix (ECM) is a structure found in animal tissue that provides 
protection and support as well many other functions. The ECM includes two components, 
the interstitial matrix and the basement membrane. The interstitial space is filled with 
polysaccharides and proteins that reduce the stress put on the ECM by buffering 
compression that occurs, while the epithelial cells rest on the basement membrane. The 
ECM is involved in the regulation of numerous biological processes including adhesion 
and migration of different cells. Specifically leukocytes are able to adhere and migrate into 
specific tissues through adhesive functions using different receptors on the ECM. For 
example, lymphocytes utilize interactions with a specific family of receptors known as 
integrins. There have been different factors implicated in the modulation of integrin 
receptors and the ECM (Springer, 1990; Hemler, 1990; Shimizu et al., 1991). The blood-
brain barrier provides a similar function to that of the ECM. Specifically, the blood-brain 
barrier serves as a selective barrier between the peripheral circulation and the central 
nervous system, and allows for the selective transport of cells in and out of the CNS. 
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However, while the BBB is more tightly regulated and controlled than the ECM, their 
underlying function is similar. The BBB includes specialized brain microvascular 
endothelial cells (BMECs), which are similar to the cells that rest on the basement 
membrane. The BBB also consists of astrocytes, pericytes, microglia, and macrophages 
(Fig. 2).  
ECM proteins provide activation signals in the form of signal transduction through 
integrins that result in functional cell changes such as adhesion and gene induction (Hynes, 
1992; Juliano et al., 1993). While the signaling pathways involved in monocyte adhesion 
are still not fully characterized, it is known that integrins can induce changes through 
signaling transduction cascades. Monocytes play an important role as one of the first lines 
of defense. They will adhere to and invade tissue when an inflammatory response is 
detected. That is, monocytes transition from a non-adherent to an adherent state relatively 
seamlessly. There are three main types of receptors that account for the transition from 
adherent to non-adherent cells, members of the Ig family, integrins, and selectins (Rosales 
et al., 1995). Of these, the most frequently found on leukocytes are members of the β 
subfamily of integrins. It has been shown that without functional β1-integrins neutrophils 
cannot respond properly to infection because they cannot adhere and cross the endothelium 
at sites of infection (Anderson et al., 1987; Kuypers et al., 1989). Integrins are known to 
act through signal transduction from the outside to the inside of the cell (Hynes, 1992; 
Larson et al., 1990; Ruoslahti, 1991). Once monocytes adhere, or are differentiated into 
macrophages using phorbol 12-myristate-13-acetate (PMA), gene induction will take place 
(Eierman et al., 1989; Sporn et al., 1990) as a consequence of signal transduction cascades 
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and cross-linking of integrins (Yurochko et al., 1992). A link also has been shown to exist 
between integrin-mediated gene induction and integrin-associated phosphorylation of 
tyrosine residues involved in signal cascades (Lin et al., 1994a). However, further 
investigation into integrin signaling pathways is required in order to fully understand the 
role of integrins in signaling.  
Cannabinoids are one of the oldest known drugs and have been shown to modulate 
immune cells both in vivo and in vitro (Cabral et al., 2009). There are two main types of 
cannabinoids, endogenous cannabinoids (endocannabinoids) such as anandamide and 2-
arachidonoyl glycerol (2-AG) that are produced naturally in vertebrates by many different 
cells. Another major type of cannabinoids are exogenous cannabinoids (exocannabinoids), 
such as the psychoactive phytocannabinoid Δ9-tetrahydrocannabinol (THC) found in the 
plant Cannabis sativa, and synthetic cannabinoids that are manufactured in the laboratory. 
One such synthetic cannabinoid is CP55940 among others.   
There are two known cannabinoid receptors found in vertebrates. The cannabinoid 
receptor type 1 (CB1R) that accounts for the psychoactive effects of the cannabis plant, 
and the cannabinoid receptor type 2 (CB2R) that frequently is found in immune cells such 
as B cells, T cells, monocytes, macrophages, and other immunocytes (Cabral & Griffin-
Thomas, 2009). Both are 7-transmembrane G-protein coupled receptors. CB1R is 
expressed primarily in the CNS while the CB2R is expressed mainly in cells of 
hematopoietic origin. CB1R and CB2R exhibit a 44% amino acid homology throughout 
the protein and 68% homology within the transmembrane domains (Oddi et al., 2011). In 
addition, the G-protein-coupled receptor 55 (GPR55) may be a novel cannabinoid receptor. 
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Although GPR55 only contains 13.5% sequence homology to the CB1R and 14.4% 
homology to the CB2R, it has been shown that a variety of cannabinoid compounds 
activate signal transduction cascades associated with GPR55, including endogenous, plant, 
and synthetic cannabinoids (Lauckner et al., 2008; Ryberg et al., 2007). Select 
cannabinoids bind these receptors and activate signaling cascades involved in numerous 
cellular processes.  
It is known that exogenous cannabinoids such as THC can have effects on immune 
system function (Cabral & Griffin-Thomas, 2009). Exogenous cannabinoids also have 
been shown to alter immune cell chemotaxis to sites of infection or inflammation (Raborn 
et al., 2008; Sacerdote et al., 2000). Most studies indicate that the receptor responsible for 
this immune function modulation is the CB2R. One of the major cellular targets of action 
for exogenous cannabinoids such as THC are macrophages and macrophage-like cells. 
Cannabinoids can suppress normal cellular functions such as phagocytosis and spreading 
as well as interfere with cell-contact-dependent lysis (Klein, 2005; Burnettecurley et al., 
1993). Current data also indicate that exogenous cannabinoids can have an inhibitory effect 
on macrophage migration by modulating trafficking during infection and inflammation 
(Cabral & Griffin-Thomas, 2009). However, definition of the full range of effects that 
exogenous cannabinoids have on macrophage and macrophage-derived cells remains to be 
defined.  
As a consequence of being highly lipophilic, cannabinoids can cross the tightly 
regulated BBB, suggesting that they may have therapeutic potential for treatment of 
neuropathological disorders characterized by inflammation. While the CB1R is typically 
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known to be functionally linked to the psychoactive effects associated with marijuana, the 
more “peripheral” CB2R is mainly involved in anti-inflammatory effects (Miller et al., 
2008). The CB2R has been identified in neurons, oligodendrocytes, and other glial cells in 
tissue and the receptor can be induced during early inflammatory events (Cabral & Griffin-
Thomas, 2009). The CB2R also has been identified in brain endothelium (Lu et al., 2008). 
While the CB2R has been well studied, there still is limited information about the effects 
of this receptor on brain endothelial cells.  
One of the major cellular effects of exogenous cannabinoids such as THC (a partial 
agonist at cannbinoid receptors) and CP55940 (a full agonist at cannabinoid receptors) is 
that they modulate cell adhesion. The cannabinoid THC acts as a partial agonist of 
cannabinoid receptors in that it only partially activates a given cannabinoid receptor. On 
the other hand, CP55940 acts as a full cannabinoid receptor agonist as it displays full 
efficacy at a given cannabinoid receptor. Not only are the expression levels of different 
adhesion molecules modified upon activation of the CB2R, but it has been shown also that 
intracellular adhesion can be decreased through CB2R signaling events that occur before 
adhesion (Ramirez et al., 2012). One CB2R agonist, JWH133, has been shown to prevent 
attachment and transendothelial migration of leukocytes in inflamed retinas (Xu et al., 
2007). Nevertheless, while the CB2R has been shown to decrease monocyte adhesion by 
altering the surface expression of certain adhesion molecules and changing the integrity of 
the tight junctions forming the BBB, the signal transduction pathway linked to these 
activites remains unknown (Ramirez et al., 2012). Several signaling pathways have been 
associated with the CB2R and its anti-inflammatory process, and while most of the 
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signaling cascades linked to its activation remain unknown there are specific cascades that 
that have been studied. For example, it has been observed that CB2R effects have been 
linked to mitogen-activated protein kinase (MAPK) signaling pathways that result in 
alteration of the production of anti-inflammatory mediators (Basu et al., 2011). Another 
pathway that has shown to be linked to CB2R signaling cascades is that involved in 
alteration of the tight junction (TJ) complex, specifically the RhoA GTPase pathway 
(Kurihara et al., 2006; Persidsky et al., 2006). Indeed, RhoA activity has been shown to 
decrease in response to CB2R attenuation (Kurihara et al., 2006).  
Previous studies in our laboratory have shown that treatment of cell lines 
resembling primary human monocytes (HL-60 and the U937 cell lines) with the HIV 
extracellular Tat protein results in increased cellular adhesion to the ECM proteins 
collagen IV and laminin, as well as to a reconstituted complex ECM substrate. Previous 
work in our laboratory has shown also that pre-treatment of these cell types with CB2R 
partial and full agonists such as THC and CP55940, respectively, results in inhibition of 
adhesion to extracellular matrix components enhanced by the Tat protein (Raborn et al., 
2013). 
Scanning electron microscopy (SEM) has shown that primary human monocytes 
undergo cytoskeletal rearrangement when treated with the Tat protein and allowed to 
adhere to collagen IV-coated coverslips for 1 hour. The cells treated with Tat protein 
assume a flattened-out appearance on coverslips and contain multiple projections 
protruding from the cell consistent with enhanced binding to the ECM. These 
morphological characteristics are distinctive from the rounded morphology that is 
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characteristic of the vehicle-treated monocytes consistent with minimal binding to the 
ECM substrates. However, when these monocytes are pre-treated with THC or CP55940 
for 2 hours followed by Tat treatment and examined for adherence to collagen IV-coated 
coverslips for 1 hour, the binding to the ECM was reduced. The cells that are pre-treated 
with THC or CP55940 appeared morphologically similar to the vehicle-treated cells (Fig. 
3). The cannabinoid pre-treated cells maintained a more rounded and non-adherent 
morphology while the cells treated only with Tat maintained their adherent state. These 
results suggest a mode by which these cannabinoids act to prevent infiltration of monocytic 
cells into the CNS, namely altering their ability to adhere to ECM substrates.  
In addition, studies have been undertaken to gain insight regarding the specific 
adhesion and migration molecules involved in cannabinoid-mediated reduction of adhesion 
of peripheral monocytes to the ECM. Confocal immunofluorescence microscopy has 
shown that THC and CP55940 alter the expression and distribution of β1-integrin and f-
actin, two molecules that play a central role in cytoskeletal rearrangement and adhesion of 
monocytes (Fig. 4).  
The goal of this project is to characterize the signal cascades involved in HIV-1 
Tat-mediated adhesion to the ECM and to determine the site of action at which THC and 
CP55940 are operative in an inhibitory way in these pathways. Due to the modulatory 
effects of cannabinoids using G-protein-coupled receptors, several specific molecules were 
observed in the β1-integrin pathway. The effects of Tat in the presence or absence of THC 
and CP55940 were observed in order to determine specific effects on signal transduction. 
Included among the studies was an examination of effects on phosphorylation of focal 
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adhesion kinase, integrin receptor signaling (i.e. MAPK), and PI3 kinase (Fig. 5). The 
hypothesis tested was that a novel convergent point existed early on in a signal 
transduction pathway between Tat-enhanced adhesion to the ECM and the cannabinoid-
induced ablation of this adhesion. Identification of a convergent point along the signal 
transduction pathway could yield novel insight into the signal transduction pathways 
involved in Tat-mediated adherence and could contribute toward development of novel 
treatment methods for HIV-associated neurocognitive disorders in which a cannabinoid 
receptor would serve as a molecular target.  
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Figure 1 – An overview of the different domains present in the HIV protein Tat. This is a 
representation of the five Tat domains: The N-terminal domain I (aa 1-20), cysteine-rich domain II (aa 
21-40), hydrophobic core domain III (aa 41-48), RNA-binding domain IV (aa 49-72), a glutamate rich 
region (aa 49-72) that is necessary for transactivation and final the C-terminal domain V of variable 
size (73-86 or 73-101) (Kuciak et al., 2008).  
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Figure 2 – The physiology of the blood brain barrier. It is made up of brain microvascular endothelial 
cells (BMECs) that are surrounded by pericytes and astrocytes. Its function is to provide a separation 
between the peripheral circulation and the central nervous system (CNS). It is very highly regulated 
and monocytes that gain entry into the CNS develop into macrophages. Tight junctions are established 
between the BMECs providing protection of the blood-brain barrier (Strazza et al., 2011). 
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Figure 3: Light and Scanning electron micrographs of U937 macrophage-like cells seeded on collagen 
IV demonstrate morphological alterations in cell adherence following treatment with Tat or with Tat 
in combination with cannabinoids. a-d- Light micrographs of U937 cells allowed to adhere (1h) to 
collagen IV-coated 96 well plates following pretreatment (2h) with: a. Vehicle (serum-free RPMI 
containing 0.01% ethanol + PBS), b. Tat (50 nM) plus 0.01% ethanol c. Tat (50 nM) plus THC (1 µM) 
and d. Tat (50 nM) plus CP55940 (1 µM). Scale bars depict 200 µM. e-k- Scanning electron 
micrographs of U937 cells seeded on collagen IV-coated coverslips illustrating morphology following 
treatment with Tat or with Tat in combinations with cannabinoids. e. Vehicle (serum-free RPMI 
containing 0.01% ethanol + PBS), f-h. Tat (50 nM) plus 0.01% ethanol, i-j. Tat (50 nM) plus THC (1 
µM), and k. Tat (50 nM) plus CP55940 (1 µM) (Courtesy of Erinn Raborn). 
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Figure 4: Treatment with THC of CP55940 alters distribution of β1- integrin and polymerized actin. 
U937 cells were pretreated (2h) with cannabinoid (THC or CP55940)(1 µM) plus Tat (50 nM), then 
seeded on collagen IV-coated chamber slides and allowed to adhere (1 h). Fixed cells were stained with 
anti-human-β1- integrin-FITC antibody followed by Phalloidin-AlexaFluor594 to visualize f-actin. Cell 
nuclei were counterstained with DAPI. The left column depicts the merged images of actin and β1- 
integrin while the right column depicts images of β1- integrin. Insets depict magnified singular cells. 
Images – 100x (Courtesy of Erinn Raborn). 
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Figure 5: A schematic overview of Rho-GTPase signaling as it pertains to cell migration. Rho, Rac and 
Cdc42 are the best-characterized members of this family of monomeric GTPases. They exert their 
action when extracellular stimuli transduce signals to upstream Rho-GTPase activators known as 
guanine nucleotide exchange factors (GEFs). Activated Rho, Rac or Cdc42 bind to downstream 
effector kinases, which then phosphorylate a plethora of substrates leading to dynamic reorganization 
of the actin cytoskeleton essential to the efficacy of directed cell migration (Rutka, 2008). 
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Table 1 – Cannabinoid Receptor Ligands 
Cannabinoid Classification Dissociation Constant (Ki) 
  CB1R ki CB2R ki 
THC Low efficacy 
CB1R/CB2R agonist 
40.7nM 36.4nM 
CP55940 High efficacy 
CB1R/CB2R agonist 
1.37nM 1.37nM 
Abbreviations – THC, (δ-tetrahydrocannabinol); CP55940, ((-)-cis-3-[2-Hydroxy-4-(1,1-
dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol) 
 
Adapted from (Howlett et al., 2002) 
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Materials and Methods 
 
 
Cell Culture 
The human promyelocytic leukemia cell line (HL-60) was obtained from ATCC, 
Manassas, VA. Cells were maintained in complete RPMI1640 medium (Cellgro, Herndon, 
VA) containing 10% fetal bovine serum and supplemented with 1% L-glutamine, 1% 
nonessential amino acids, 1% minimal essential medium vitamins, 0.01 M HEPES, and 
penicillin (100U/mL)/streptomycin (100 ug/ml)/fungizone (0.25ug/ml)(Cellgro). Cell 
cultures were maintained at 37oC with 5% CO2 in ventilated T-175 flasks (Greiner Bio 
One, Monroe, NC). For cell lines that were differentiated into macrophages complete 
RPMI was supplemented with either 1µM all-trans-retinoic acid (Fischer Scientific, 
Waltham, MA) or 16 nM phorbol 12-myristate-13-acetate (Fisher Scientific #BP685-1). 
Tat 
Recombinant human HIV-1 Tat1-86 protein (E. coli) was obtained from 
Immunodiagnostics, Inc. (Woburn, MA). Tat was dissolved in sterile sodium citrate (10 
uM) and frozen aliquots were stored at -80oC until converted to a working solution 
according to the manufacturer’s recommendation. For in vitro administration, special low-
retention microfuge tubes (Thermo Fisher Scientific, Waltham, MA) and low-binding 
pipette tips (VWR, West Chester, PA) were used to minimize Tat loss.  
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Cannabinoids  
The partial CB1 receptor/ CB2 receptor (CB1R/CB2R) agonist Delta-9-tetrahydrocannbinol 
and the full CB1R/CB2R agonist CP55940 were obtained from the Department of 
Pharmacology and Toxicology (Virginia Commonwealth University, Richmond, VA). 
Stock solutions of cannabinoids (10-2 M) were prepared in 100% ethanol and stored at -20 
oC. Experimental concentrations were obtained by dilution of cannabinoid stock solutions 
in assay medium (RPMI 1640 medium) to yield a final ethanol concentration of 0.01%. 
The vehicle control for cannabinoids consisted of 0.01% ethanol in a medium for 
cannabinoid treatment, equal volume of sterile sodium citrate for Tat treatments, or 0.01% 
ethanol plus sodium citrate for cannabinoid/Tat treatments.  
Western ImmunoBlot Analysis for CB2R, GPR55, and B1-integrin probes 
For Western immunoblot analysis, cells were centrifuged (1000 x g, 10 min, 4oC) and 
pellets were washed with room temperature PBS (2x) then resuspended in serum-free 
RPMI 1640. The cells were lysed using dH2O containing 1% protease inhibitor cocktail 
(Sigma-Aldrich #P8340-1ML) and subjected to freeze-thawing 4 times using liquid 
nitrogen and a room temperature water bath. The protein concentration of lysates was 
determined using the Bradford method (Bradford, 1976), and 30 µg of protein were 
subjected to separation in a 10% SDS-polyacrylamide gel (SDS-PAGE). After 
electrotransfer to a nitrocellulose membrane using a Fischer Scientific FB200 apparatus the 
membranes were blocked in 5% non-fat milk in Tris-buffered saline (TBS), containing 
0.2% -Tween 20 (TBST) for 1h at room temperature. The membranes then were washed (5 
min) in TBST and incubated overnight at 4oC with primary antibody in 5% milk in TBST. 
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Primary antibodies consisted of anti-CB2R diluted 1:100 in 5% milk/TBST (Nowell et al., 
1998), anti-GPR55 5µg/mL in 5% milk/TBST (Caymen Chemical #10224), and anti-β1-
integrin diluted 1:1000 in 5% milk/TBST (Sigma-Aldrich #GW22754). Membranes were 
washed with TBST (3 times, 5 min each) and incubated with the appropriate secondary 
antibodies, anti-CB2R utilized goat anti-rabbit at 1:5,000 dilution in 5% milk/TBST, anti-
GPR55 utilized goat anti-rabbit at 1:5,000 dilution in 5% milk/TBST, anti-β1-integrin 
utilized rabbit anti-chicken at 1:10,000 dilution in 5% milk/TBST. After 6 washes with 
TBST (5 min each), the membranes were subjected to enhanced chemiluminescence 
according to the manufacturer’s instructions (GE Healthcare, Cleveland, OH) . 
Western ImmunoBlot Analysis for Focal Adhesion Kinase 
For Western immunoblot analysis, cells were centrifuged (1000 x g, 10 min, 4oC) and 
pellets were washed with room temperature PBS (2x) then resuspended in serum-free 
RPMI 1640. The cells were lysed using the modified Radio Immunoprecipitation Assay 
(RIPA) buffer mentioned previously plus a 1% protease inhibitor cocktail (Sigma-Aldrich 
#P8340-1ML). The protein concentration of lysates was determined using the Bradford 
method (Bradford, 1976) and 30 µg of protein were subjected to separation in a 10% SDS-
PAGE. After electrotransfer to a nitrocellulose membrane using a Fischer Scientific FB200 
apparatus the membranes were blocked in 5% non-fat milk in Tris-buffered saline (TBS), 
containing 0.2% -Tween 20 (TBST) for 1h at room temperature. The membranes then were 
washed (5 min) in TBST and incubated overnight at 4oC with primary antibody in 5% BSA 
in TBST at a dilution of 1:1,000. Primary antibodies consisted of rabbit anti-mouse focal 
adhesion kinase or phosphorylated focal adhesion kinase proteins (Cell Signaling 
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Technology #3283 and #3285, respectively). Membranes were washed with TBST (3 
times, 5 min each) and incubated with secondary horseradish peroxidase-conjugated goat 
anti-rabbit antibody at a dilution of 1:2,000 in 5% milk/TBST. After 6 washes with TBST 
(5 min each), the membranes were subjected to enhanced chemiluminescence according to 
the manufacturer’s instructions (GE Healthcare, Cleveland, OH). 
Scanning Electron Microscopy 
For attachment assays wells were coated with ECM gel (Sigma-Aldrich, St. Louis, MO) 
from Engelbreth-Holm-Swarm murine on the day of use. Upon polymerization, ECM gel 
forms a reconstituted basement membrane containing laminin, type IV collagen, heparan 
sulfate proteoglycan, enactin, and other minor components. ECM gel stock (stock solutions 
8-12 mg/mL) was washed 2x with PBS, then diluted 1:3 in RPMI without serum and added 
to wells for 10 min at room temperature. To examine for adhesion to the ECM, HL 60 cells 
(105) were pretreated with vehicle (serum-free RPMI containing 0.01% ethanol drug and 
sodium citrate) or Tat (50nM) alone or in combination with cannabinoid (THC, CP55940; 
1µM) then incubated (2 h, 37oC) on tissue culture inserts coated with to an ECM gel 
described above. The inserts then were immersed for 1 hour in 2.5% glutaraldehyde in 
0.1M cacodylate buffer, pH 7.2, washed four times with PBS, and treated (40 min in the 
dark) with 2% osmium tetroxide buffered in 0.1M cacodylate buffer, pH 7.2. The inserts 
were washed with PBS, dehydrated in a graded series of ethanol dilutions, subjected to 
critical-point drying with CO2 as the transitional fluid, mounted on stubs and coated with 
gold (30nm) (Rocha-Azevedo et al., 2007). Samples were examined in a Zeiss EVO 
50XVP scanning electron microscope operating at an accelerating voltage of 15 kV. 
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Sample Preparation for detection of p-Tyr Proteins Using Microarrays  
To prepare HL-60 lysates and cell-conditioned media, 1x107 HL-60 cells were seeded in a 
6-well plate with complete RPMI. After two days, complete medium was replaced with 
serum free RPMI. Supernatants and cells were collected separately 48h later. To prepare 
cell lysate, cells were lysed with a modified RIPA buffer mentioned previously plus a 1% 
protease inhibitor cocktail (Sigma-Aldrich #P8340-1ML) and protein concentrations were 
determined using the Bradford method (Bradford, 1976).  
Detection of p-Tyr Proteins Using Microarrays  
Microarrays were performed according to RayBio Human RTK Phosphorylation Antibody 
Array (RayBiotech, Inc., Norcross, GA, USA). First, the array was blocked using a 
blocking buffer provided by RayBio. Next, a lysate concentration of 600 µg were loaded 
onto each plate for the different treatment conditions. The plates were then incubated 
overnight at 4oC. Unbound materials were washed away using TBST and biotinylated anti-
phosphotyrosine antibody was added. The plates were then incubated for 2 h at room 
temperature. After another wash, streptavidin-conjugated HRP antibodies were added and 
the plates were incubated for another 2 h at room temperature. After extensive washing, 
detection was performed using chemiluminesence detecting with film. Densitometry was 
then performed by scanning the arrays and using QuantiOne software from Bio-Rad 
(Hercules, CA) and standards were generated using the controls provided on the plate. The 
relative densities of the samples were determined by comparison to the standards provided. 
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Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
Real-time Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for extracellular 
matrix and adhesion molecules (SABiosciences #PAHS-128Z) was used for detection of 
adhesion and extracellular matrix molecules to assess the levels of mRNA. HL-60 cells 
were treated with vehicle (serum-free RPMI + Sodium citrate + 0.01% ethanol), 50 nM 
Tat, 50nM Tat + 1µM CP55940, or 50nM Tat + 1µM THC suspended in serum-free RPMI 
and incubated at 37ºC in 5% CO2 for 8 h. Total RNA was prepared using TRIzol reagent 
(Invitrogen) according to the manufacturer’s instruction. The RNA was extracted using 
chloroform:isopropanol and resuspended in 30 uL PCR grade water. The isolated RNA 
was treated with RNase-free DNase I Amplification grade (QUIAGEN) to remove residual 
genomic DNA. Reverse transcription (RT) was performed in a Bio-Rad iCycler (BioRad, 
Richmond, VA) using the RT2 First Strand Synthesis Kit (QIAGEN) used to generate 
complimentary DNA (cDNA). The cDNA template was combined with an instrument 
specific and ready-to-use RT2 SYBR Green qPCR Master Mix. Equal aliquots of this 
mixture (25 uL) were added to each well of the same PCR Array plate containing the 
predispensed gene-specific primer sets (QIAGEN). The plates containing the PCR mix 
were placed in the SmartCycler (Cepheid, Sunnyvale, CA)  and PCR was performed using 
the following program: 95°C, 15 min; 40 cycles of (95°C, 30 sec; 55°C, 30 sec; and 72°C, 
30 sec). The resulting PCR products were calculated using the threshold cycle (Ct) values 
for all the genes on the PCR Array. Fold changes in the gene expression in pairs were 
calculated using the ΔΔCt method. Built-in RNA quality controls were also utilized to 
provide the relative levels of genomic DNA contamination and inhibitors of either the 
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reverse transcription or the PCR itself. By examining the Ct value consistency for the 
housekeeping genes a normalization method was determined.  
RhoA Activation Sample Preparation and Lysate Collection 
HL-60 Cells were plated into 6-well FALCOLN multi-well plates. Cells were grown in 
cell culture media under the conditions described above for 4 days and supplemented with 
1µM all-trans-retinoic acid (ATRA) as described under the cell culture conditions to 
differentiate them into macrophage-like cells. After 4 days cells were switched to serum-
free RPMI onto plates coated with human fibrinogen. Plates coated with human fibrinogen 
were prepared by coating plates with 100ug/mL of human fibrinogen (Invitrogen) 
suspended in PBS and incubated at 4ºC overnight. Prior to use the unpolymerized human 
fibrinogen was removed and washed away with PBS. After switching the cells to 
fibrinogen coated plates and serum-free RPMI, they were incubated overnight. HL-60 cells 
were then treated with 50nM Tat at different time points in the presence and absence of 
cannabinoids (THC, CP55940 at 1µM) at specific time points between 30 sec and up to 30 
min. Following treatment under given experimental conditions the treatment was removed 
and the cells were washed 2x with ice-cold PBS. Cells were then lysed using a lysis buffer 
provided by Cytoskeleton (#CLB01-S) supplemented with 1% Protease Inhibitor Cocktail 
(Sigma-Aldrich #P8340-1ML) and harvested by scraping the adherent cells from the plate. 
Lysates were snap-frozen in liquid nitrogen and stored at -80ºC for further analysis. Protein 
concentration was determined using the Bradford Assay (Bradford, 1976). 
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RhoA Activation Pulldown Assay 
Pulldown assays were performed on activated RhoA using a Biochem Kit (Cytoskeleton 
#BK036-S, Denver, CO). The pulldown assay was performed according to the protocol 
provided by Cytoskeleton. 
Western ImmunoBlot Analysis for RhoA Activation 
For Western immunoblot analysis, 25 µg of protein were subjected to separation on either 
a 10% or 12% SDS-PAGE. After electrotransfer to a nitrocellulose membrane using a 
Fischer Scientific FB200 apparatus the membranes were blocked in 5% non-fat milk in 
Tris-buffered saline (TBS), containing 0.2% -Tween 20 (TBST) for 1h at room 
temperature. The membranes then were washed (5 min) in TBST and incubated overnight 
at 4oC with anti-RhoA mouse monoclonal antiboides (Cytoskeleton #ARH03) in TBST at 
a dilution of 1:500. Membranes were washed with TBST (1 time, 5 min) and incubated 
with secondary horseradish peroxidase-conjugated goat anti-mouse antibody (Organon 
Teknika Corp., Westchester, PA #55550). After 6 washes with TBST (10 min each), the 
membranes were subjected to enhanced chemiluminescence according to the 
manufacturer’s instructions (GE Healthcare). 
Statistics  
One Way Analysis of Variance (ANOVA) was performed to assess for differences 
between treatment groups. Bonferroni’s t-test was used to compare differences in Tat-
treated cells versus cells treated with cannabinoid in the presence of Tat, in addition to 
differences between treatment groups. 
  36 
 
 
Results 
 
 
 
Human Promyelocytic Leukemia cell (HL-60) Expression of the Cannabinoid Receptor 
CB2R, GPR55, and B1-integrin Receptor 
 The cannabinoids THC and CP55940 bind to cannabinoids receptors CB1, CB2 and 
GPR55 (Herkenham et al., 1990). Therefore in order to show that the cell line used in 
present study expresses these receptors, SYBR Green RT-PCR for the CB1R, CB2R, and 
GPR55 mRNA was employed. A 207 bp amplicon that is consistent with the size predicted 
for CB2R was detected in the total mRNA extracted from the HL-60 cells (Fig. 6).  
Whole cell lysates of HL-60 cells were subjected to western immunoblotting using 
a mouse CB2R and GPR55 domain-specific antibody to confirm the presence of CB2R and 
GPR55 (Fig. 7). The presence of the β1-integrin receptor was also probed for since it plays 
a critical role in cytoskeletal rearrangement and adhesion (Lafrenie et al., 1996). HL-60 
whole cell lysates were also used to probe for the β1-integrin receptor using an Anti-
Integrin β1 antibody produced in chicken (Fig. 8). Based on these data HL-60 cells were 
shown to express these proteins at both the mRNA and protein levels. 
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Figure 6 – CB2R mRNA expressed in human promyelocytic leukemia cells (HL-60). RT-PCR revealed 
amplification of a 207 bp amplicon consistent with the presence of CB2R mRNA. (-) – negative dH2O 
control 
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Figure 7 – Human Promyelocytic Leukemia cells (HL-60) Express the CB2R and GPR55 at the protein 
level. Whole cell lysates from HL-60 cells were separated by SDS-PAGE followed by Western 
immunoblot analysis with antibodies to the CB2R, GPR55, or Actin. After stripping of the membrane 
actin detection was performed on the corresponding membrane that was used to detect CB2R or 
GPR55. 
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Figure 8 – Human Promyelocytic Leukemia cells (HL-60) Express β1-integrin at the protein level. 
Whole cell lysates from HL-60 cells were separated by SDS-PAGE followed by Western immunoblot 
analysis with antibodies to β1-integrin and Actin. After stripping of the membrane actin detection was 
performed on the corresponding membrane that was used to detect β-integrin. 
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Tat induces Cytoskeletal Rearrangement in HL-60 Promyelocytic Cells. 
When human promyelocytic leukemia cells were treated with 50nM Tat over a 10 
min time point a time-dependent reorganization of f-actin was observed. Treatment using 
50nM Tat protein demonstrated induction of actin polymerization over a 20 min time 
course (Fig. 9a and Fig. 9b). 
Similarly, when HL-60 cells were observed attaching and penetrating an ECM gel 
(Sigma) using scanning electron microscopy following treatment with 50nM Tat and a 
vehicle treatment, further evidence of cytoskeletal rearrangement was observed (Fig. 10). 
Fingerlike projections were noted for in the Tat-treated cells showing adherence whereas 
minimal projections were seen for vehicle-treated cells (not shown here).  
 
 
 
 
 
 
 
 
 
 
 
 
Vehicle Tat 
Tat Tat 
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Figure 9a - HL-60 cells were seeded on glass coverslips and differentiated with complete RPMI containing 10% FBS and 
phorbol 12-myristate-13-acetate (PMA) (16nM, 4days). HL-60 cells were treated with Vehicle (RPMI+ sodium citrate)(0 
min) or 50 nM Tat (5-20 min), then fixed with 4% paraformaldehyde. Actin polymerization was visualized by staining the 
coverslips with AlexaFluor-Phalloidin (1:500)(2h). ProLong Gold Antifade Reagent containing the nuclear counterstain 
DAPI was used to mount the coverslips and stabilize the fluorescent signal.  Scale bars- 100mm    
 
0:10 
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Figure 9b – 20x Images, HL-60 cells were seeded on glass coverslips and differentiated with complete RPMI containing 10% 
FBS and phorbol 12-myristate-13-acetate (PMA) (16nM, 4days). HL-60 cells were treated with Vehicle (RPMI+ sodium 
citrate)(0 min) or 50 nM Tat (5-20 min), then fixed with 4% paraformaldehyde. Actin polymerization was visualized by 
staining the coverslips with AlexaFluor-Phalloidin (1:500)(2h). ProLong Gold Antifade Reagent containing the nuclear 
counterstain DAPI was used to mount the coverslips and stabilize the fluorescent signal.  Scale bars- 300mm    
Vehicle Tat 
Tat Tat 
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Figure 10: Scanning electron micrographs of HL-60 macrophage-like cells seeded on ECM gel (Sigma 
Aldrich) demonstrate morphological alterations in cell adherence following treatment with 50nM Tat 
(10 µM) (Courtesy of Dr. F.M. Cabral). Control images not shown.  
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Receptor Tyrosine Kinase (RTK) Multiplex Assay of Human Promyelocytic Leukemia Cells 
shows Tat up-regulates specific RTK-Molecules while the Cannabinoids THC and 
CP55940 down-regulate the same Molecules.  
 In order to identify a possible signal transduction cascade involved in both Tat 
induced inflammation and cannabinoid inhibited inflammation, phosphorylation levels of 
specific tyrosine kinase (TK) molecules were assessed. TKs have been implicated in many 
cellular processes. Often these occur through the transfer of a phosphate group to a 
substrate. This phosphorylation can induce changes at the cytoskeletal level including 
attachment and invasion of certain cells. Concurrently, such phosphorylation can activate 
or inhibit different cellular processes. In view of these effects the phosphorylation of 
different TKs was evaluated. Using a tyrosine kinase array, an increase in phosphorylation 
of several TKs was seen at a 10 min time point for cells treated with Tat as compared to 
cells treated only with vehicle. The phosphorylation levels of these TKs then decrease 
towards baseline at the 20 min time point (Fig. 12). Maximal phosphorylation was 
observed following treatment using 50nM Tat at the 10 min time point.  
 In order to identify the effects of cannabinoids on the phosphorylation levels of the 
specific tyrosine kinase molecules, HL-60 cells were treated with 50nM Tat concurrently 
with CP55940 or THC. Cells were also treated only with CP55940 in order to confirm that 
a cannabinoid by itself did not alter phosphorylation of the indicated protein species. 
Phosphorylation was observed in cells treated with vehicle, 50nM Tat, 50nM Tat treatment 
+ cannabinoid. Several of the receptor tyrosine kinases demonstrated an increase in 
phosphorylation upon exposure to Tat. This phosphorylation was diminished upon 
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cannabinoid treatment in concert with the Tat exposure (Fig. 14a. & b.). Specifically, 
phosphorylation of TKs Fgr, Pyk2, and Syk was modulated by the introduction of 
cannabinoids. Each of these 3 molecules is involved in the Rac-Rho β-integrin cellular 
adhesion pathway. 
 The TK membranes contained intrinsic positive controls found in row 1, A through 
F. The densitometry of the 3 different positive controls for each membrane was determined 
in duplicate and the results were standardized to the differences in the positive controls. 
Similarly the density of each TK was also done in duplicate, averaged and standardized 
using the 3 separate positive controls.  This approach allowed for the determination of 
relative densities of the different TKs while still adjusting for variance between the plates.  
 
 
   
 46 
	  
 
Figure 11 –RTK phosphorylation multiplex assay for adhesion and invasion. HL-60 lysates were 
prepared and used to probe the array, cells were treated with Vehicle (RPMI + sodium citrate), 50nM 
Tat for 10 min., and 50nM Tat for 20 min. The grid depicts the topography of the blots for the 
different receptor tyrosine kinases. 
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Figure 12 –Quantitative data from Fig. 11. The graph depicts greater than 2-fold increase of 
phosphorylation levels compared to vehicle treatment (RPMI+ sodium citrate + 0.01% Ethanol) of 
50nM Tat treatments at 10 min (Red) and 20 min (Purple). Densitometry was then performed on the 
membranes and results were graphed according to optical density. Receptor Tyrosine Kinases 
phosphorylation showing less than 2-fold change were not included in the graph.   
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Figure 13 - Receptor Tyrosine Kinase (RTK) phosphorylation multiplex assay for adhesion and 
invasion. HL-60 cells were lysed and prepared using methods described by RayBio® protocol. HL-60 
cells were treated with Vehicle (RPMI + sodium citrate); 50nM Tat for 10 min.; 1µM CP55940 for 10 
min., 50nM Tat +  1µM CP55940 for 10 min; 50nM Tat + 1µM THC for 10 min. The grid depicts the 
topography of the blots for the different receptor tyrosine kinases. 
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Figure 14a – Graph showing treatment of HL-60 cells with 50 nM Tat protein for 10 min. shown in 
blue; and 50nM Tat protein + CP55940 for 10 min. shown in red compared to vehicle (serum-free 
RPMI + sodium citrate + 0.01% ethanol) for 10 min. and plotted as fold change. Densitometry was 
performed on the membranes and the results were graphed according to optical density. Receptor 
Tyrosine Kinases phosphorylation showing less than 2-fold change were not included.   
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Figure 14b – Graph showing treatment of HL-60 cells with 50 nM Tat protein for 10 min. shown in 
blue; and 50nM Tat protein + CP55940 for 10 min. shown in red compared to vehicle (serum-free 
RPMI + sodium citrate + 0.01% ethanol) for 10 min. and plotted as fold change. Densitometry was 
performed on the membranes and the results were graphed according to optical density. Receptor 
Tyrosine Kinases phosphorylation showing less than 2-fold change were not included.   
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Tat Protein does not alter Focal Adhesion Kinase (FAK) Expression nor FAK 
Phosphorylation in HL-60 Cells that are differentiated into Macrophages 
 Phosphorylation at Tyr-397 was assessed because this residue was implicated in 
autophosphorylation that mediates cellular adhesion (Calalb et al., 1995) (Fig. 5). The 
tyrosine kinase FAK was observed using western blot analysis probing with specific 
polyclonal antibodies detecting phosphorylation at Tyr-397 for the FAK molecule. HL-60 
cells were differentiated into macrophage-like cells over 4 days using phorbol 12-
myristate-13-acetate (PMA). Detection of phosphorylation at tyrosine-397 on the molecule 
FAK was performed using western blot analysis after treatment of cells with 50nM Tat 
protein at time points ranging between zero and twenty minutes. A time-dependent 
increase was observed in the phosphorylation of tyrosine-397 on focal adhesion kinase 
between five and ten minutes after treatment of 50 nM Tat protein (Fig. 15a). However, 
this increase in phosphorylation was also observed in the vehicle treated cells (Fig. 15b). 
This increase is likely due to the fact that sodium citrate can also act as an activating agent. 
 Expression levels of unphosphorylated FAK were also observed at different time 
points to assess the expression levels of the FAK protein during treatment with Tat. Again, 
HL-60 cells were differentiated into macrophage-like cells using PMA over a 4-day period. 
Detection of the FAK protein was performed using western immunoblotting after 
treatments of either vehicle or 50nM Tat at given time points. Increased levels of FAK 
were seen for Tat treatments at 10 and 20 min as compared to vehicle (0 min. stimulation). 
A protein band was observed that corresponded to an approximate relative molecular 
weight of 50 kD which is not the predicted size of the full-length FAK protein (Fig. 15). 
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The predicted molecular weight of FAK was 125 kDa, which is different from the 
observed 50 kDa band. Since no significant alteration was seen in the phosphorylation of 
FAK the next molecule in the β-integrin signaling transduction pathway, RhoA, was 
investigated. 
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Figure 15 – Western immunoblot of HL-60 cells differentiated over 4 days using phorbol myristate 
acetate. Cells were treated with (a). 50nM Tat for 2.5, 5, 10, and 20 min or (b). Vehicle (sodium citrate 
+ 0.01% ethanol). Lysates were prepared using a modified RIPA buffer and western immunoblotting 
was performed according to the Cell Signaling Technology® protocol. FAK phosphorylated antibodies 
were used to detect phosphorylation levels of FAK (Cell Signaling Technologies #3283). α-Actin was 
used as a control for proper loading of each lane with equal concentrations of protein.   
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Figure 16 – Western immunoblot of HL-60 cells differentiated over 4 days using phorbol 12-myristate-
13-acetate. Cells were treated with either Vehicle (sodium citrate + 0.01% ethanol) or 50nM Tat for 
2.5, 10, and 20 min. Lysates were prepared using a modified RIPA buffer and western immunoblotting 
was performed according to the Cell Signaling Technology® protocol. FAK antibodies were used to 
detect phosphorylation levels of FAK (Cell Signaling Technologies #3285). α-Actin was used as a 
control for proper loading of each lane with equal concentrations of protein. 
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Transcripts for Proteins Linked to Extracellular Matrix and Adhesion or Cell Motility 
Molecules are not affected by Tat in the Presence and Absence of Cannabinoid 
In order to determine if mRNA expression of adhesion molecules is altered in the 
context of Tat in the presence or absence of cannabinoids, an RT-PCR array kit from 
SABiosciences observing cell motility was employed. HL-60 cells were plated and treated 
with vehicle (sodium citrate + 0.01% ethanol), 50nM Tat, 50nM Tat + 1µM THC, 50nM 
Tat + 1µM CP55940 and placed in the incubator for 8 h. RNA extraction was then 
performed on the cells, the isolated RNA was added to a cDNA template in equal aliquots 
and RT-PCR was employed to quantitate the mRNA expression of the different genes. 
Vehicle treatments were first compared to the 50nM Tat treatments and a scatter plot was 
generated comparing Tat treatment to vehicle (Fig. 17). A heat map was also generated 
comparing Tat treatments to the vehicle treatments (Fig. 18). No statistically significant 
differences in mRNA gene expression were seen in the 84 genes probed on the RT-PCR 
Array Plate when comparing 50nM Tat treatment to vehicle treatment. 
The 50nM Tat treatment alone was then compared to 50nM Tat treatment in the 
presence of cannabinoids. A scatter plot was generated comparing Tat treatments to Tat + 
THC treatment (Fig. 19). Also a heat map was generated comparing the two (Fig. 20).  In 
addition, a scatter plot (Fig. 21) and heat map (Fig. 22) were generated comparing Tat 
treatments to Tat + CP55940. No statistically significant differences were seen when 
comparing the RT-PCR of Tat treatments to Tat treatments with cannabinoids during an 8h 
time point. Table 2 demonstrates the position of the different mRNAs on the plate as well 
as a brief description of the cognate genes and alternative description designations.  
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Figure 17 – Scatter plot of the 84 key genes involved in cell movement and attachment comparing 
vehicle vs. Tat treatments. The graph depicts Vehicle treatment (sodium citrate + 0.01% ethanol) on 
the X-axis (Control Group) plotted vs. 50nM Tat treatment along the Y-axis (Group 1). Expression has 
been normalized using housekeeping genes present on the array and the scatter plot allows for quick 
visualization of large gene expression changes. The central line indicates gene expression changes and 
the boundaries indicate 2-fold increases or decreases in expression.  
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Figure 18 - Heat plot of 50nM Tat vs. Vehicle (Sodium citrate + 0.01% ethanol). This plot provides a 
graphical representation of fold regulation expression data between two groups overlaid onto the PCR 
Array plate layout. The brighter green represents a decrease in mRNA levels of the particular gene 
whereas the brighter red indicates an up-regulation of the mRNA levels of the particular gene as 
compared to Vehicle (sodium citrate + 0.01% ethanol). Grey represents no data present for the gene.  
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Figure 19 – Scatter plot of the 84 key genes involved in cell movement and attachment comparing Tat 
vs. Tat + THC. The graph depicts 50nM Tat + 1 µM THC treatment along the X-axis (Group 2) vs. 
50nM Tat treatment on the Y-axis (Group 1) plotted. Expression has been normalized using 
housekeeping genes present on the array and the scatter plot allows for quick visualization of large 
gene expression changes. The central line indicates gene expression changes and the boundaries 
indicate 2-fold increases or decreases in expression.  
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Figure 20 – Heat plot of 50nM Tat + THC vs. 50nM Tat. This plot provides a graphical representation 
of fold regulation expression data between two groups overlaid onto the PCR Array plate layout. The 
brighter green represents a decrease in mRNA levels of the particular gene whereas the brighter red 
indicates an up-regulation of the mRNA levels of the particular gene as compared to 50nM Tat 
treatments. Grey represents no data present for the gene.  
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Figure 21 – Scatter plot of the 84 key genes involved in cell movement and attachment comparing Tat 
vs. Tat + CP55940. The graph depicts 50nM Tat + 1 µM CP55940 treatment along the X-axis (Group 
3) vs. 50nM Tat treatment on the Y-axis (Group 1) plotted. The expression has been normalized using 
housekeeping genes present on the array and the scatter plot allows for quick visualization of large 
gene expression changes. The central line indicates gene expression changes and the boundaries 
indicate 2-fold increases or decreases in expression.  
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Figure 22 - Heat plot of 50nM Tat + CP55940 vs. 50nM Tat. This plot provides a graphical 
representation of fold regulation expression data between two groups overlaid onto the PCR Array 
plate layout. The brighter green represents a decrease in mRNA levels of the particular gene whereas 
the brighter red indicates an up-regulation of the mRNA levels of the particular gene as compared to 
50nM Tat. Grey represents no data present for the gene.  
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Position Symbol Description Gene Name 
A01 ACTN1 Actinin, alpha 1 FLJ40884, FLJ54432 
A02 ACTN3 Actinin, alpha 3 MGC117002, MGC117005 
A03 ACTN4 Actinin, alpha 4 ACTININ-4, DKFZp686K23158, FSGS, 
FSGS1 
A04 ACTR2 ARP2 actin-related protein 2 homolog 
(yeast) 
ARP2 
A05 ACTR3 ARP3 actin-related protein 3 homolog 
(yeast) 
ARP3 
A06 AKT1 V-akt murine thymoma viral oncogene 
homolog 1 
AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, 
RAC, RAC-ALPHA 
A07 ARF6 ADP-ribosylation factor 6 DKFZp564M0264 
A08 ARHGDIA Rho GDP dissociation inhibitor (GDI) 
alpha 
GDIA1, MGC117248, RHOGDI, RHOGDI-1 
A09 ARHGEF7 Rho guanine nucleotide exchange 
factor (GEF) 7 
BETA-PIX, COOL-1, COOL1, 
DKFZp686C12170, DKFZp761K1021, 
KIAA0142, KIAA0412, Nbla10314, P50, 
P50BP, P85, P85COOL1, P85SPR, PAK3, 
PIXB 
A10 BAIAP2 BAI1-associated protein 2 BAP2, FLAF3, IRSP53 
A11 BCAR1 Breast cancer anti-estrogen resistance 
1 
CAS, CAS1, CASS1, CRKAS, FLJ12176, 
FLJ45059, P130Cas 
A12 CAPN1 Calpain 1, (mu/I) large subunit CANP, CANP1, CANPL1, muCANP, muCL 
B01 CAPN2 Calpain 2, (m/II) large subunit CANP2, CANPL2, CANPml, FLJ39928, 
mCANP 
B02 CAV1 Caveolin 1, caveolae protein, 22kDa BSCL3, CGL3, MSTP085, VIP21 
B03 CDC42 Cell division cycle 42 (GTP binding 
protein, 25kDa) 
CDC42Hs, G25K 
B04 CFL1 Cofilin 1 (non-muscle) CFL 
B05 CRK V-crk sarcoma virus CT10 oncogene 
homolog (avian) 
CRKII 
B06 CSF1 Colony stimulating factor 1 
(macrophage) 
MCSF, MGC31930 
B07 CTTN Cortactin EMS1, FLJ34459 
B08 DIAPH1 Diaphanous homolog 1 (Drosophila) DFNA1, DIA1, DRF1, FLJ25265, LFHL1, 
hDIA1 
B09 DPP4 Dipeptidyl-peptidase 4 ADABP, ADCP2, CD26, DPPIV, TP103 
B10 EGF Epidermal growth factor HOMG4, URG 
B11 EGFR Epidermal growth factor receptor ERBB, ERBB1, HER1, PIG61, mENA 
B12 ENAH Enabled homolog (Drosophila) ENA, MENA, NDPP1 
C01 EZR Ezrin CVIL, CVL, DKFZp762H157, FLJ26216, 
MGC1584, VIL2 
C02 FAP Fibroblast activation protein, alpha DKFZp686G13158, DPPIV, FAPA 
C03 FGF2 Fibroblast growth factor 2 (basic) BFGF, FGFB, HBGF-2 
C04 HGF Hepatocyte growth factor (hepapoietin 
A; scatter factor) 
DFNB39, F-TCF, HGFB, HPTA, SF 
C05 IGF1 Insulin-like growth factor 1 
(somatomedin C) 
IGF-I, IGF1A, IGFI 
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C06 IGF1R Insulin-like growth factor 1 receptor CD221, IGFIR, IGFR, JTK13, MGC142170, 
MGC142172, MGC18216 
C07 ILK Integrin-linked kinase DKFZp686F1765, ILK-2, P59 
C08 ITGA4 Integrin, alpha 4 (antigen CD49D, alpha 
4 subunit of VLA-4 receptor) 
CD49D, IA4, MGC90518 
C09 ITGB1 Integrin, beta 1 (fibronectin receptor, 
beta polypeptide, antigen CD29 
includes MDF2, MSK12) 
CD29, FNRB, GPIIA, MDF2, MSK12, VLA-
BETA, VLAB 
C10 ITGB2 Integrin, beta 2 (complement 
component 3 receptor 3 and 4 subunit) 
CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, 
MFI7 
C11 ITGB3 Integrin, beta 3 (platelet glycoprotein 
IIIa, antigen CD61) 
CD61, GP3A, GPIIIa 
C12 LIMK1 LIM domain kinase 1 LIMK, LIMK-1 
D01 MAPK1 Mitogen-activated protein kinase 1 ERK, ERK2, ERT1, MAPK2, P42MAPK, 
PRKM1, PRKM2, p38, p40, p41, p41mapk 
D02 MET Met proto-oncogene (hepatocyte 
growth factor receptor) 
AUTS9, HGFR, RCCP2, c-Met 
D03 MMP14 Matrix metallopeptidase 14 
(membrane-inserted) 
1, MMP-14, MMP-X1, MT-MMP, MT-MMP 1, 
MT1-MMP, MT1MMP, MTMMP1 
D04 MMP2 Matrix metallopeptidase 2 (gelatinase 
A, 72kDa gelatinase, 72kDa type IV 
collagenase) 
CLG4, CLG4A, MMP-II, MONA, TBE-1 
D05 MMP9 Matrix metallopeptidase 9 (gelatinase 
B, 92kDa gelatinase, 92kDa type IV 
collagenase) 
CLG4B, GELB, MANDP2, MMP-9 
D06 MSN Moesin - 
D07 MYH10 Myosin, heavy chain 10, non-muscle MGC134913, MGC134914, NMMHCB 
D08 MYH9 Myosin, heavy chain 9, non-muscle DFNA17, EPSTS, FTNS, MGC104539, MHA, 
NMHC-II-A, NMMHCA 
D09 MYL9 Myosin, light chain 9, regulatory LC20, MGC3505, MLC2, MRLC1, MYRL2 
D10 MYLK Myosin light chain kinase DKFZp686I10125, FLJ12216, KRP, MLCK, 
MLCK1, MLCK108, MLCK210, MSTP083, 
MYLK1, smMLCK 
D11 PAK1 P21 protein (Cdc42/Rac)-activated 
kinase 1 
MGC130000, MGC130001, PAKalpha 
D12 PAK4 P21 protein (Cdc42/Rac)-activated 
kinase 4 
- 
E01 PFN1 Profilin 1 - 
E02 PIK3CA Phosphoinositide-3-kinase, catalytic, 
alpha polypeptide 
MGC142161, MGC142163, PI3K, p110-alpha 
E03 PLAUR Plasminogen activator, urokinase 
receptor 
CD87, U-PAR, UPAR, URKR 
E04 PLCG1 Phospholipase C, gamma 1 NCKAP3, PLC-II, PLC1, PLC148, 
PLCgamma1 
E05 PLD1 Phospholipase D1, 
phosphatidylcholine-specific 
- 
E06 PRKCA Protein kinase C, alpha AAG6, MGC129900, MGC129901, PKC-alpha, 
PKCA, PRKACA 
E07 PTEN Phosphatase and tensin homolog 10q23del, BZS, DEC, GLM2, MGC11227, 
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MHAM, MMAC1, PTEN1, TEP1 
E08 PTK2 PTK2 protein tyrosine kinase 2 FADK, FAK, FAK1, FRNK, pp125FAK 
E09 PTK2B PTK2B protein tyrosine kinase 2 beta CADTK, CAKB, FADK2, FAK2, PKB, PTK, 
PYK2, RAFTK 
E10 PTPN1 Protein tyrosine phosphatase, non-
receptor type 1 
PTP1B 
E11 PXN Paxillin FLJ16691 
E12 RAC1 Ras-related C3 botulinum toxin 
substrate 1 (rho family, small GTP 
binding protein Rac1) 
MGC111543, Rac-1, TC-25, p21-Rac1 
F01 RAC2 Ras-related C3 botulinum toxin 
substrate 2 (rho family, small GTP 
binding protein Rac2) 
EN-7, Gx, HSPC022 
F02 RASA1 RAS p21 protein activator (GTPase 
activating protein) 1 
CM-AVM, CMAVM, DKFZp434N071, GAP, 
PKWS, RASA, RASGAP, p120GAP, 
p120RASGAP 
F03 RDX Radixin DFNB24 
F04 RHO Rhodopsin CSNBAD1, MGC138309, MGC138311, OPN2, 
RP4 
F05 RHOA Ras homolog gene family, member A ARH12, ARHA, RHO12, RHOH12 
F06 RHOB Ras homolog gene family, member B ARH6, ARHB, MST081, MSTP081, RHOH6 
F07 RHOC Ras homolog gene family, member C ARH9, ARHC, H9, MGC1448, MGC61427, 
RHOH9 
F08 RND3 Rho family GTPase 3 ARHE, Rho8, RhoE, memB 
F09 ROCK1 Rho-associated, coiled-coil containing 
protein kinase 1 
MGC131603, MGC43611, P160ROCK, 
PRO0435 
F10 SH3PXD2A SH3 and PX domains 2A FISH, SH3MD1, TSK5 
F11 SRC V-src sarcoma (Schmidt-Ruppin A-2) 
viral oncogene homolog (avian) 
ASV, SRC1, c-SRC, p60-Src 
F12 STAT3 Signal transducer and activator of 
transcription 3 (acute-phase response 
factor) 
APRF, FLJ20882, HIES, MGC16063 
G01 SVIL Supervillin DKFZp686A17191 
G02 TGFB1 Transforming growth factor, beta 1 CED, DPD1, LAP, TGFB, TGFbeta 
G03 TIMP2 TIMP metallopeptidase inhibitor 2 CSC-21K 
G04 TLN1 Talin 1 ILWEQ, KIAA1027, TLN 
G05 VASP Vasodilator-stimulated phosphoprotein - 
G06 VCL Vinculin CMD1W, CMH15, MVCL 
G07 VEGFA Vascular endothelial growth factor A MGC70609, MVCD1, VEGF, VPF 
G08 VIM Vimentin FLJ36605 
G09 WASF1 WAS protein family, member 1 FLJ31482, KIAA0269, SCAR1, WAVE, 
WAVE1 
G10 WASF2 WAS protein family, member 2 SCAR2, WAVE2, dJ393P12.2 
G11 WASL Wiskott-Aldrich syndrome-like DKFZp779G0847, MGC48327, N-WASP, 
NWASP 
G12 WIPF1 WAS/WASL interacting protein family, 
member 1 
MGC111041, PRPL-2, WASPIP, WIP 
   
 65 
H01 ACTB Actin, beta PS1TP5BP1 
H02 B2M Beta-2-microglobulin - 
H03 GAPDH Glyceraldehyde-3-phosphate 
dehydrogenase 
G3PD, GAPD, MGC88685 
H04 HPRT1 Hypoxanthine 
phosphoribosyltransferase 1 
HGPRT, HPRT 
H05 RPLP0 Ribosomal protein, large, P0 L10E, LP0, MGC111226, MGC88175, P0, 
PRLP0, RPP0 
H06 HGDC Human Genomic DNA Contamination HIGX1A 
H07 RTC Reverse Transcription Control RTC 
H08 RTC Reverse Transcription Control RTC 
H09 RTC Reverse Transcription Control RTC 
H10 PPC Positive PCR Control PPC 
H11 PPC Positive PCR Control PPC 
H12 PPC Positive PCR Control PPC 
Table 2 - Topographical representation of the PCR Array Plate. The different extracellular matrix and 
adhesion molecules present on the PCR Array Plate, their respective location on the plate, and a brief 
description of the genes and other known names of the specific genes are indicated.  
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Tat and the Cannabinoids CP55940 and THC do not alter the activation of RhoA in HL-60 
Cells  
The RhoA protein has two states, an activated GTP bound form, and an inactive 
GDP bound form. The GTP bound form has been implicated in β-integrin and cytoskeletal 
rearrangement and thus was chosen as a possible convergent point in the signal 
transduction pathway (Palazzo et al., 2004) involving action mediated by extracellular Tat 
in concert with the select cannabinoids CP55940 and THC (Fig. 5). 
The first steps taken were to identify an optimal time point for Tat treatment where 
the most activated form of RhoA could be observed. Therefore, once the macrophage-like 
cells had been differentiated and had adhered to the human fibrinogen coated plates they 
were treated with 50nM Tat for a time course ranging from 0 sec to 5 min (Fig. 23a). Since 
these preliminary experiments indicated that it appeared that the optimal time point was 
most likely outside of the 5 min window, longer treatment conditions were applied and Tat 
treatments were observed over a 30 min window (Fig. 23b). These experiments indicated 
that optimal Tat treatment time points for eliciting the highest expression of RhoA were 15 
min and 30 min. 
Based on these observations, treatments of vehicle, Tat, cannabinoids, and Tat + 
cannabinoids were performed at 15 min and 30 min to assess for RhoA activation. First, 
the total level of RhoA protein was observed using western immunoblotting (Fig. 24a) and 
then a “pull-down” assay was performed using the Rhotekin Binding Domain (RBD) kit 
that utilizes beads that will pull down only the active, GTP bound, form of RhoA (Fig. 
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24b). The beads containing the RBD domain were divided into 30µg and then HL-60 
lysate samples were washed over the beads for one hour. Residual protein was then washed 
away and the remaining activated (GTP –bound) RhoA was detected using western 
immunoblotting. No significant differences were observed in the active GTP bound RhoA 
under any of the treatment conditions.  
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Figure 23- Western immunoblot of HL-60 cells differentiated over 4 days using all-trans-retinoic acid 
(ATRA) and allowed to adhere to human fibrinogen coated plate. Cells were treated with Vehicle 
(Sodium Citrate + 0.01% ethanol) or 50nM Tat for a range of (a). 60s to 300s and (b). 5m to 30m. 
Lysates were prepared using a lysis buffer provided by Cytoskeleton® and prepared following their 
protocol. Anti-RhoA antibodies were used to detect levels of RhoA (Cytoskeleton #ARH03-A). α-Actin 
was used as a control for proper loading of each lane with equal concentrations of protein. A positive 
control of RPMI-1640 containing serum was utilized according to Cytoskeleton.   
   
 69 
  
Figure 24- Western immunoblot of HL-60 cells differentiated over 4 days using all-trans-retinoic acid 
(ATRA) and allowed to adhere to a human fibrinogen coated plate. Cells were treated with Vehicle 
(Sodium Citrate + 0.01% ethanol), 50nM Tat, 10-6M CP55940/THC, or 50nM Tat + 10-6M 
CP55940/THC for either 15m or 30m. Lysates were prepared using a lysis buffer provided by 
Cytoskeleton® and prepared following their protocol. Anti-RhoA antibodies were used to detect levels 
of RhoA (Cytoskeleton #ARH03-A).  
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Discussion 
 
 
 
Since the advent of HAART survival rates of patients infected with HIV-1 have 
increased. However, this increase in survival is tempered by the development of HIV-
Associated Neurocognitive Disorders (HAND). The CNS is invaded by the transmigration 
of leukocytes that act as viral reservoirs and migrate across the blood-brain barrier (BBB) 
(Buckner et al., 2006). Acting as viral reservoirs, infected macrophage-like cells secrete a 
broad range of molecules from chemokines and cytokines to toxic viral proteins such as 
HIV glycoprotein 120 (gp120) and Tat. These HIV-associated events lead to increased 
inflammation in the brain as a consequence of deregulation of immunocytes and 
compromise of the BBB contributing to increased entry of infected as well as uninfected 
activated leukocytes.  
Extracellular Tat protein has been shown to alter adhesion and cell morphology of 
monocytes and macrophages to the endothelium as well as the ECM (Matzen et al., 2004; 
Barillari et al., 1993). Specifically, Tat has been implicated in the invasion of monocytes 
into reconstituted basement membranes of the ECM as well as increasing their adhesion to 
endothelial monolayers (Lafrenie et al., 1996).  Similarly, an increase in Tat levels has 
been shown to occur synergistically with TNFα resulting in increased adhesion to 
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endothelial cells both in vitro and in vivo (Matzen et al., 2004). Even though infected 
monocytes/macrophages are the predominate HIV positive cells located in the brain, the 
mechanism for their entry into the CNS is poorly understood. While HIV-1 Tat has been 
shown to increase adherence of monocytes to endothelial cells as well as the ECM, select 
cannabinoids such as THC and CP55940 have been shown to decrease adherence and 
invasion of monocytes in a mode that is linked functionally to the CB2R (Rajesh et al., 
2007; Ramirez et al., 2012). The recognition that such immune modulation uses the CB2R 
as a molecular target has emerged as a potential way to treat neurocognitive disorders as 
well as modulate immune system function (Cabral & Griffin-Thomas, 2009; Klein, 2005).  
It has been shown that extracellular Tat increases expression of adhesion molecules 
of macrophage-like cells thus enhancing monocyte-adhesion as well as monocyte-
endothelium interactions (Lafrenie et al., 1996) while cannabinoids inhibit these effects 
(Raborn et al., 2012). Based on this information initial microscopy studies were performed 
in order to gain further insight regarding adherence and cytoskeletal rearrangement taking 
place when Tat-treated cells are allowed to adhere to different ECM components (Raborn 
et al., 2013). By confocal microscopy it was possible to observe morphological changes 
and rearrangement in β-integrin as well as actin polymerization in macrophage-like cells. 
Both U937 and HL-60 cells are human myelogenous leukemia-derived cell lines that can 
be differentiated in vitro by chemical agents and thus are often used as models to study the 
terminal differentiation of myelomonocytic cells. It was observed that rearrangement of 
cytoskeletal elements occurred in HL-60 cells that was accompanied by increased 
adherence to the ECM, similar to the U937 cell line, suggesting that the attachment process 
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resulted in signal transduction activation of these cells and that such activation occurred 
early in the adhesion process. Based on results early events in the signal transduction 
cascades that could be linked to cytoskeletal rearrangement were investigated.   
Adhesion molecules play a key role in the invasion of monocytes/macrophages 
from the peripheral circulation into tissue. The movement of monocytes/macrophages from 
peripheral circulation into tissue occurs in three separate phases involving different 
adhesion molecules. First, P-selectins initiate early adhesion as leukocytes are “rolling” 
through the circulatory system. Next, when these leukocytes are exposed to activating 
agents such as chemoattractants or phorbol 12-myristate-13-acetate (PMA), they become 
extremely adhesive to the endothelium. This interaction involving the endothelium and the 
leukocytes, appears to mediate the activation of β2-integrins resulting in increased 
adhesion, cytoskeletal rearrangement, and “spreading” of the leukocytes (Kuijpers et al., 
1990; Lo et al., 1989). However, the molecular nature for this change in β-intergrin affinity 
is unknown, although their increased adhesiveness is well documented (Springer, 1994). 
Once these integrins are activated, there is a greater interaction with endothelial 
intercellular adhesion molecules (ICAMs) and vascular cellular adhesion molecules 
(VCAMs) leading to more robust adhesion of the leukocytes. Finally, once the integrins 
are activated they enable strong adhesion of the cell to the endothelium allowing 
diapedisis, the movement of blood cells from peripheral circulation into the body tissue, to 
occur and invasion of the leukocytes to take place.  
The effects of Tat on adhesion and infiltration of monocytes is well documented, 
specifically with regard to inflammatory processes and adhesion. Moreover, Tat has been 
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shown to regulate intracellular adhesion molecules (ICAMs) and vascular cell adhesion 
molecules (VCAMs) as well as the integrin family of proteins. Similarly, Tat has been 
shown to up-regulate the expression of β2-integrein adhesion molecules as well as 
increasing monocyte adhesion (Lafrenie et al., 1996; Lafrenie et al., 1996; Lafrenie et al., 
1997).  HIV-1 Tat has also been shown to increase leukocyte adhesion to the endothelium 
in vivo (Matzen et al., 2004). Integrins act as receptors capable of creating biochemical 
signals that act through secondary messengers within the cell. Many of these secondary 
messengers and pathways are well documented (reviewed in (Rosales et al., 1995), and 
these signaling events warrant future research. Specifically, a connection between integrin 
activated gene induction and tyrosine phosphorylation has been demonstrated (Lin et al., 
1994b). Since there is a cascade of tyrosine phosphorylation between integrin gene 
induction and integrin-mediated adhesion, it is worth looking at downstream elements in 
the integrin signal transduction pathway. Specific pathways implicated in Tat activation 
are ERK and JNK MAP kinases (Ganju et al., 1998; Gu et al., 2001) that control cell fate 
decisions of monocytes as they adhere and undergo diapedesis. Also, Tat has been shown 
to cause actin rearrangement through activation of Ste20 kinase p21/cdc 42/Rac-activated 
kinase (PAK). The principal activators of PAK1, Rac1, and Cdc42 are members of the Rho 
GTPase family (Wu et al., 2007). 
It is well documented that Tat enhances adhesion and inflammatory processes in 
monocytes through signal transduction cascades involving integrins. Specifically Tat 
signal transduction is primarily pro-inflammatory causing increased invasion, as well as 
cytokine and chemokine production. Select cannabinoids have been reported to decrease 
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the presence of these adhesion molecules (Rajesh et al., 2007; Ramirez et al., 2012; Pu et 
al., 2003). While Tat has been shown to increase adhesion of monocytes to the 
endothelium as well as the production of pro-inflammatory molecules, treatment with 
cannabinoids that act through the CB2R has resulted in a decrease in adhesion and 
invasion of monocytes as well as decreasing the production of pro-inflammatory molecules 
(Rajesh et al., 2007; Ramirez et al., 2012). More specifically, cannabinoid receptors 
produce signals that regulate nuclear DNA binding factors through a cAMP-independent 
MAP kinase pathway that is used for regulation of gene transcription (Berdyshev, 2000). 
Several other molecules have been reported to be involved in CB2R signaling, including 
phosphatidylinositol 3-kinase (PI3K), and members of the mitogen-activated protein 
kinase NF-kB families, which are involved in the anti-inflammatory events, associated 
with cannabinoids (Kurihara et al., 2006). 
Both Tat and cannabinoids have been implicated in modulating cell signaling in a 
variety of ways that include involvement of adhesion and invasion as well as cytokine and 
chemokine production. Specifically, since cannabinoids that bind the CB2R act as anti-
inflammatory agents through signal transduction cascades cannabinoids appear to have 
viable potential in reducing Tat-associated inflammation through signal transduction 
events. One of the most well studied signal transduction pathways involving Tat and 
cannabinoids is the integrin signal transduction pathway. The specific signal transduction 
cascade involving integrin receptors begins when ligands bind to the extracellular domain 
of integrins causing changes in their conformation resulting in clustering. Then since 
integrins lack kinase activity they utilize secondary messenger tyrosine kinases. 
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Specifically FAK is phosphorylated at Tyr-397 once ligand binding occurs followed by 
activation of a Rho GTPase resulting in modulation of phosphorylation of the myosin light 
chain (MLC) as well as the ERM family. These molecules then go on to modulate stress 
fiber formation as well as actin contraction. Several molecules of this pathway have been 
examined including Rac, Ras, ERK, MAPK, Rho, FAK as well as many other signal 
transduction molecules. Based on the microscopy involving β-integrin reorganization as 
well as actin polymerization it seemed plausible to conclude that there was a convergent 
point along one of these two signal transduction cascades linked to the effects of 
extracellular Tat protein and the cannabinoids THC and CP55940.   
 In order to assess some of the possible signal transduction cascades that could be 
implicated in this cytoskeletal rearrangement and to identify candidate pathways, several 
high-throughput methods were employed. The first approach entailed the use of a proof-of-
principle Tyrosine Kinase (TK) phosphorylation array, which examined 71 different 
human TKs and their phosphorylation. Tyrosine kinases are important regulators of 
intracellular signal transduction pathways as well as mediators of multicellular 
communications (Adachi et al., 2007). There are two major types of tyrosine kinases, 
receptor tyrosine kinases (RTKs) and non-receptor protein tyrosine kinases (PTKs). PTKs 
constitute a large family of different molecules including Src, Janus kinases (Jaks) and Abl 
along with others. The Src family of kinases (SFKs) is the largest and plays an important 
role in signaling in a variety of different cell types. When different stimuli activate surface 
receptors they stimulate SFKs that transduce signals to different downstream signaling 
factors. Among several of the SFKs are Lck, Lyn, Hck, Fgr, and Blk, along with others 
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(Adachi & Suzuki, 2007). The kit employed for this study allowed for monitoring of 
different TKs via phosphorylation as a means to implicate a specified signaling pathway as 
linked to cytoskeletal rearrangement. Since there are numerous pathways involved in cell 
adhesion, this kit served as a tool for a starting point to look at multiple molecules in order 
to gain insight regarding an involved pathway. One of the key pathways examined was the 
β-integrin pathway that is involved in cell adhesion to the ECM.  
The membranes were treated with 50nM Tat protein at both 10 and 20 min in order 
to find the optimal time point for TK phosphorylation. The concentration of 50nM was 
chosen based on previous studies performed in the laboratory (Fraga et al., 2011). Once the 
optimal time point was determined, the effects of THC and CP55940 were observed. Again 
concentrations of 10-6M of both THC and CP55940 were used.  The TKs Fgr, Pyk2, 
SRMS, Syk, and TXK were shown because they displayed an increased level of 
phosphorylation consistent with their activation by Tat. These molecules also showed a 
decreased level of Tat-engendered phosphorylation upon treatment with THC and 
CP55940 + Tat, consistent with involvement of a signal transduction pathway in the 
cannabinoid-mediated effect on adhesion to cytoskeletal elements. Based on these data, the 
β-integrin pathway seemed like the most promising target point to examine as modulation 
by select cannabinoids was observed for FAK a non-receptor tyrosine kinase involved in 
the β-integrin pathway as well as Pyk2 which is a proline-rich homologue to FAK (Recher 
et al., 2004).  
While FAK and Pyk2 share many characteristics, they also exhibit key differences. 
FAK signals for both PI3K and MAPK that are involved in cell motility; however, Pyk2 
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can display a proapoptotic function resulting in apoptosis due to exposure to certain drugs 
or cytokines (Recher et al., 2004). It has been documented that FAK is weakly expressed 
in murine immature myeloid precurosors (Kume et al., 1997). Similarly, FAK is expressed 
in leukocytes, but not in macrophages (Denichilo et al., 1993; Levesque et al., 1999; 
Fuortes et al., 1994). While FAK and Pyk2 share a 45% overall sequence similarity FAK 
phosphorylation occurs at six sites while only four of these sites are present in Pyk2. 
However, the major role of signal transduction involving the Src family kinases (SFKs) 
remains the same. Additionally Pyk2 is not only regulated by phosphorylation, but also by 
calcium signaling. Finally, while FAK is localized in focal adhesion-plaques, Pyk2 can be 
found in the perinuclear areas (Nakamura et al., 2001).  
Additionally, modulation was seen in Fgr, a non-receptor tyrosine kinase that is a 
member of the Src family kinases involved in β-integrin signaling. Further analysis of the 
different molecules affected by Tat and select cannabinoids is required in order to isolate 
signal transduction molecules specifically involved in cytoskeletal rearrangements that are 
targeted by cannabinoids.  
 Next, a proof-of-principle human cell motility RT-PCR array plates were used as a 
high-throughput method to identify a specific signal transduction pathway implicated in 
the cytoskeletal rearrangement of macrophage-like cells caused by the interaction of Tat 
and THC or CP55940. Specifically, the levels of mRNAs for select molecules involved in 
human cell motility were assessed under given experimental conditions. The plate used 
allowed for the identification of mRNAs from 84 genes involved in the movement of cells 
including actin rearrangement as well as cytoskeleton mobilization. A time point of 8h was 
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chosen for assessment of effects based on previous studies that were performed in the 
laboratory in which rat primary microglial cells were used (Puffenbarger et al., 2000). Each 
dot on the scatter plot represents one of the 84 key genes linked to the movement of the 
cells. The dots are distributed along the line indicating no change in mRNA expression 
according to their different levels represented in logarithmic form. These different 
expression levels are also standardized to housekeeping genes present on the RT-PCR 
plate.  
Based on the RT-PCR mRNA expression analysis no statistical differences were 
observed in any of the genes on the array. This was not surprising as cytoskeletal 
rearrangements such as actin polymerization and β-integrin expression levels are transient 
events. Thus, had the mRNA levels under the given experimental conditions been read at 
multiple time points along the 8h window it would have been far more likely that the 
expression level of the mRNA for specific genes involved in cytoskeletal rearrangement 
and mobility could have changed. Another possible explanation for the absence of 
response is that the Tat protein used was from a T-lymphocyte-tropic strain (IIIB). There is 
another Tat protein available from a monotropic strain (BAL) as well as a dual-tropic 
strain. Given that the HL-60 cells are of myeloid origin it is possible that a BAL Tat would 
engender a more robust response. Further analysis would need to be done in order to show 
this however.  
Work was then begun to characterize the regulatory molecules involved in the β-
integrin signal transduction pathway. While the mechanism by which HIV alters monocyte 
gene expression remains unknown it has been shown that treatment of monocytes with 
   
 79 
extracellular Tat changes β1-integrin expression levels (Lafrenie et al., 1996). Our work 
with cellular staining and visualization of β1-integrin expression yielded similar results. 
However, it has been shown that pre-treatment of cells with THC and CP55940 reduces 
this increased expression of β1-integrin presenting, a putative signal transduction pathway 
convergent point for signal transductional activities linked to the interaction of 
extracellular Tat and select cannabinoids. Therefore, it is thought that along this β1-integrin 
signal transduction pathway involving adhesion there is a putative convergent point at 
which both extracellular Tat protein and THC or CP55940 acts.  
One of the key molecules associated with adhesion and migration is focal adhesion 
kinase (FAK). FAK is a non-receptor tyrosine kinase that localizes to regions of the cell 
that attach to the ECM. Specifically FAK will coordinate signals from integrins as well as 
growth factors to localize and adhere to the ECM. FAK is involved in 
autophosphorylation, and one of the major sites of this is Tyr-397 (Recher et al., 2004). 
The phosphorylation at Tyr-397 is necessary for Src binding to FAK which is an essential 
step in promoting cell migration (Cary et al., 1996). Similarly, activation of integrins that 
occurs when cells bind to the ECM leads to an increase in FAK tyrosine phosphorylation 
(Guan et al., 1991; Kornberg et al., 1991; Burridge et al., 1992). Therefore, FAK 
phosphorylation at Tyr-397 was observed under different experimental conditions using 
western immunoblot analysis in triplicate to determine whether the focal adhesion 
molecules were involved in an interaction between extracellular Tat and THC or CP55940.  
Following differentiation of HL-60 cells into macrophage-like cells assessment of 
phosphorylation at Tyr-397 was undertaken in order to determine whether integrin 
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activation lead to ECM binding. Differential time points were used in order to determine 
the optimal time point for Tat treatment before treating with Tat and in concert with THC 
or CP55940. However, problems arose in that the focal adhesion kinase was a difficult 
protein to isolate and thus levels of phosphorylation were difficult to determine. No 
statistical differences were seen between vehicle-treated cells when compared to Tat-
treated cells when observing phosphorylation of FAK. Increases in phosphorylation were 
observed at the 5 and 10 minute time points in both Tat and vehicle-treated cells, most 
likely due to the fact that sodium citrate can act as an activating agent. Later it was found 
that FAK is weakly expressed in monocytes/macrophages (Choi et al., 1993; Denichilo & 
Burns, 1993; Yamada et al., 1997; Lin et al., 1994a; Roach et al., 1997) suggesting that the 
action of FAK might be carried out by Pyk2. This is because Pyk2 is a molecule that is 
highly expressed in monocytes and macrophages (Hatch et al., 1998). Therefore it is most 
likely that had the western immunoblot analysis been done for Pyk2 as opposed to focal 
adhesion kinase better results would have been obtained.  
 While integrins lack intrinsic tyrosine kinase activity there are signaling events 
involved in their clustering and adhesion to the ECM. One of the early events in integrin 
signaling is the phosphorylation of focal adhesion kinase mentioned above (Kumar, 1998). 
This phosphorylation will, in turn, lead to the activation of the GTPase RhoA (Palazzo et 
al., 2004). Through such events in the signal transduction cascade integrins are able to 
mediate the adhesion and spreading of specific cells to the ECM (Barillari et al., 1999a). It 
has been shown that once FAK phosphorylation takes place numerous secondary 
messengers are then activated, including that of RhoA (Urbinati et al., 2005). This 
   
 81 
activation of RhoA does not occur solely through the β-integrin pathway but is still a major 
step in the pathway. 
 One of the difficulties in observing the RhoA protein is that the cognate antibody 
will bind both the active and inactive forms of RhoA. Thus it is necessary to use beads for 
the Rhotekin Binding Domain (RBD) to pull down the active, GTP bound, form of RhoA. 
Upon treatment of macrophage-like cells with Tat, cannabinoids (i.e. THC or CP55940), 
and Tat + cannabinoids both total RhoA protein and the active GTP bound RhoA were 
observed. Based on experiments performed previously using HL-60 cells and cannabinoids 
that act through the CB2R, human fibrinogen was used as a coating medium to allow for 
macrophage adherence. It has been shown that RhoA activation levels decrease in HL-60 
cells when the cells are differentiated into macrophage-like cells and attached to human 
fibrongen (Kurihara et al., 2006).  
 Based on the previous work done on HL-60 cells and RhoA using the CB2R the 
conditions were replicated for a proof-of-principle experiment by coating plates with 
human fibrinogen and treating with Tat, cannabinoids, and Tat + cannabinoids. There was 
no statistical difference obtained in levels of total RhoA protein when cells were 
maintained in the presence or absence of Tat and/or THC or CP55940. However, the level 
of total RhoA protein was decreased when the Tat + THC or CP55940 treated cells were 
observed via western immunoblotting.  
 To check whether this decrease was caused by modulation of the active, GTP 
bound, form of RhoA a pull down assay was conducted using the Rhotekin Binding 
Domain (RBD), which is a domain that only binds the active GTP bound form of RhoA. 
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After detecting the active GTP bound form of RhoA, it was determined that there was no 
statistical difference in the amount of RhoA-GTP bound protein present under the given 
treatment conditions. Thus, there was a significant decrease in the total RhoA protein 
under Tat + cannabinoid treatment conditions but no difference in the active GTP bound 
form under these same conditions.  
 Based on the observations of total RhoA compared to GTP bound RhoA it is most 
likely that under the Tat + cannabinoid treatment conditions there is some sort of RhoA 
degradation. It does not appear that any degradation of the RhoA protein is under the Tat 
and cannabinoid treatment conditions. Therefore, in order to further investigate these 
findings the experiment needs to be repeated in order to show reproducibility. Upon 
successful reproduction of the same results it is probable that the RhoA molecule is being 
sequestered or there is some sort of cross talk between molecules involving RhoA. In order 
to resolve this event confocal microscopy could be used under the given treatment 
conditions to observe the sequestration of the RhoA protein into a different compartment 
under the Tat + cannabinoid treatment conditions.  
 Further work needs to be conducted starting with the repetition and investigation of 
the possible sequestration of the RhoA under the Tat and cannabinoid treatment conditions. 
Confocal microscopy can be used in order to determine whether this molecule is being 
relocated under these conditions. Similarly since monocytes/macrophages do not express 
FAK well it is also important to further investigate the expression levels of the homolog 
Pyk2. This molecule has strong similarity to FAK and could serve as a convergent point 
along the β-integrin signal transduction cascade since they both act on RhoA. While it is 
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highly probable that this putative convergent point exists somewhere along a signal 
transduction cascade a definitive answer has not yet been resolved but some novel insight 
into which pathways to look at and what molecules may be implicated has been 
established. Similarly, while it is probable that the CB2R is being induced there is no direct 
evidence that has yet been obtained that indicates a functional linkage to any signal 
transductional pathway that is involved in cell motility.  Specific agonists and antagonists 
of the CB2R could be utilized as well as knockouts and siRNA to resolve the involvement 
of the CB2R in this process. 
 In summary, the first goal of this study was to determine if Tat-enhanced 
attachment to an extracellular matrix substrate was affected by cannabinoids. Confocal 
microscopy and SEM demonstrated that Tat-enhanced adhesion to an ECM substrate was 
inhibited by the cannabinoids THC or CP55940. The second goal was to determine if this 
Tat-enhanced attachment activated a signal transductional pathway, and that such 
activation was affected by the cannabinoids THC and CP55940.  Although several signal 
transductional pathways were shown to be activated by Tat, a definitive role of 
cannabinoids and their modulation remains to be defined. Similarly whether a cannabinoid 
receptor is linked functionally to the inhibition of adhesion to an ECM component remains 
to be defined.   
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